Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xuexin Liu
Observed name:
X. Liu
Institution:
Hebei General Hospital
Observed institutions:
Peking Union Medical College Hospital,
Hebei General Hospital
ORCID:
0000-0001-9799-0730
Observed ORCID:
0000-0001-9799-0730
OpenAlex ID:
A5019057898
Pyroptosis-Mediator GSDMD in Plasma: A Potent Biomarker Lung Cancer Diagnosis and Prognosis Assessment
2025
·
Xuexin Liu
, Fang Yu
, et al.
·
International Journal of General Medicine
·
5
PDF
Pyroptosis-Mediator GSDMD in Plasma: A Promising Biomarker for Early Diagnosis of Type 2 Diabetes
2025
·
Lijing Huo
, Xuexin Liu
, et al.
·
Diabetes Metabolic Syndrome and Obesity
·
3
PDF
Pyroptosis-mediator Gasdermin D in serum: a potential biomarker in diabetic kidney disease
2026
·
Nan Ding
, Changmei Wei
, et al.
·
Frontiers in Endocrinology
·
2
PDF
WITHDRAWN: 1892P The clinical characteristics, treatment, and prognosis of lung cancer in young patients in the new era of cancer treatment: A retrospective and comprehensive analysis
2025
·
X. Feng
, S. Li
, et al.
·
Annals of Oncology
·
1
The Diagnostic and Progressive Value of Serum GSDMD in Patients with Heart Failure: A Retrospective Study
2025
·
Changmei Wei
, Nan Ding
, et al.
·
International Journal of General Medicine
PDF
9124 POSTER Nimotuzumab in Combination With Chemotherapy in the Patients With Advanced Non-small Cell Lung Cancer
2011
·
H. Wang
, L. Li
, et al.
·
European Journal of Cancer
Show more works
View as search
Works count:
6
Citation count:
11
H-index:
2
I10-index:
Year
Topic
Type